| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/05/2005 | CN1182845C Anticonvulsant derivatives for treating cluster headaches |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838580 Opioid derivative |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838470 Antiischemic agents; brain disorders; cardiovascular disorders |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838465 N-acyltetrahydroisoquinoline derivatives |
| 01/04/2005 | US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
| 01/04/2005 | US6838434 Methods for treating sinus headache |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838253 Using an enzyme inhibitor of 11 beta -reductase; administering carbenoxolone |
| 01/04/2005 | US6838249 Identifying transport protein modulator using gabapentin (GBP) as a transfer/fluid flow indicator; anticonvulsant; neuropathic pain |
| 01/04/2005 | US6838093 System for osmotic delivery of pharmaceutically active agents |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/04/2005 | CA2340999C 5-arylindole derivatives |
| 01/04/2005 | CA2332406C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 01/04/2005 | CA2250929C 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/04/2005 | CA2242015C New chromene derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 01/04/2005 | CA2148827C Novel 3,3-diphenylpropylamines, their use and preparation |
| 01/04/2005 | CA2102072C Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence |
| 12/30/2004 | US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 12/30/2004 | US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040267004 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 12/30/2004 | US20040266991 Biologically active peptides and their use for repairing injured nerves |
| 12/30/2004 | US20040266874 Contains, as active ingredient, arachidonic acid and/or a compound having arachidonic acid as a constituent fatty acid and, particularly, an alcohol ester of arachidonic acid or a triglyceride, phospholipid or glycolipid in which all or a portion of constituent fatty acids are arachidonic acid |
| 12/30/2004 | US20040266871 Methods for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
| 12/30/2004 | US20040266866 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266863 Use of (11beta,17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/30/2004 | US20040266819 Using a 2-aminoquinoline compound |
| 12/30/2004 | US20040266815 Alzheimer's disease, bipolar disorder, diabetes, dementia, stroke, schizophrenia, depression, hair loss, cancer |
| 12/30/2004 | US20040266812 (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
| 12/30/2004 | US20040266807 Controlled release hydrocodone formulations |
| 12/30/2004 | US20040266799 Corticotropin-releasing factor (CRF); such as 4-chloro-2-methyl-5-nitro-8-(2,4-dichloro)phenyl-1,7-naphthyridine for treating stroke, anxiety, depression, and/or irritable bowel syndrome |
| 12/30/2004 | US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 12/30/2004 | US20040266792 Hydroxyrisperidone compositions and methods |
| 12/30/2004 | US20040266791 risperidone dihydrochloride, risperidone hydrogenmaleate, risperidone hemitartrate and risperidone hemimalate |
| 12/30/2004 | US20040266790 formed by contacting a risperidone donor suchas risperidone acetate with a chloride ion donor such as HCl in a solvent; serotonin antagonist approved for the treatment of psychotic disorders such as schizophrenia |
| 12/30/2004 | US20040266781 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266776 Methods of preventing and reducing the severity of stress-associated conditions |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266757 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040266674 For diagnosis, therapy, prevention of cell proliferation, autoimmune disease, antiinflammatory agents, cardiovascular disorders, central nervous system disorders; isolated nucleic acids; genetic engineeringo |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265958 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265847 Administering zinc binding agent (sodium citrate) to modulate interaction within central nervous system between zinc and/or heparin with amyloid precursor proteins |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265403 nutraceuticals comprising plant extracts used as neuroprotectants and cognition activators |
| 12/30/2004 | US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265380 Orodispersible effervescent tablets |
| 12/30/2004 | US20040265369 Compounds that inhibit caspase activity for treating glaucoma |
| 12/30/2004 | US20040265366 Nanocorpuscles having lipid bilayer with biliar salt and phospholipid and metallothionein in the interior; nervous system and neurodegenerative disorders; Alzheimer*s and Parkinson*s disease; multiple sclerosis, amyotrophic lateral sclerosis, viral and bacterial meningitis, spongiform encephalopathy |
| 12/30/2004 | US20040265363 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 12/30/2004 | US20040265358 Modified methionine rich food products and process for their manufacture |
| 12/30/2004 | US20040265308 Prevention and treatment of amyloidogenic disease |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265283 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 12/30/2004 | US20040265279 Administering to a subject a bacterial strain of Lactobacillus or Bifidobacterium; Cushing's disease, anxiety, psychological disorders |
| 12/30/2004 | US20040265242 Administering drug to the respiratory tract of patient in a lower dosage than orally; treating Parkinson's or Alzheimer's disease; sleep, attention deficit hyperactivity, bipolar, and psychological disorders; headaches, antiepileptic agents; rescue therapy for a panic attack |
| 12/30/2004 | US20040265239 Buccal, polar and non-polar spray containing zolpidem |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/29/2004 | WO2004113568A2 Methods for the diagnosis and prognosis of alzheimer's disease |
| 12/29/2004 | WO2004113367A1 Peptide having apoptosis-inhibiting activity |
| 12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 12/29/2004 | WO2004113336A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 12/29/2004 | WO2004113334A1 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | WO2004113333A1 Therapeutic agent for senile dementia |
| 12/29/2004 | WO2004113326A1 Indole derivatives as serotonin reuptake inhibitors |
| 12/29/2004 | WO2004113325A1 Indole derivative in the form of serotonin reabsorbing inhibitors |
| 12/29/2004 | WO2004113306A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |